Compare Organon Pharma Indonesia Tbk. (SCPI) vs Dosni Roha Indonesia Tbk. (ZBRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Dosni Roha Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Dosni Roha Indonesia Tbk. trades at Rp50 (market cap 125.54B). The key difference: Dosni Roha Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | ZBRA | |
|---|---|---|
Market Cap | 104.4B | 125.54B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Dosni Roha Indonesia Tbk.
PT Zebra Nusantara Tbk. (the Company) was founded on January 8th, 1987 under the name PT Zebra Taxi. The Company, which started its operation on April 1987 with 25 taxi units has developed rapidly into a company with the biggest taxi fleet in Surabaya. On January 23, 1996, the Capital Market Supervisory Board (Bapepam) approved the tender offered by PT Infiniti Wahana to buy PT Zebra Nusantara’s shares at Rp 2,625 per share.
Read more on ZBRA →
